Literature DB >> 11597594

Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion.

A E Badr1, W Yin, G Mychaskiw, J H Zhang.   

Abstract

We have shown that hyperbaric oxygen (HBO) reduced cerebral infarction in rat middle cerebral artery occlusion model (MCAO). The present study was undertaken to evaluate the effect of HBO on ischemic striatal metabolites at different times after MCAO and reperfusion. A rat MCAO model was produced via the intraluminal filament method. After 2 h of occlusion the suture was removed and reperfusion was allowed. The rats were sacrificed at 24 h after reperfusion. HBO treatment was administered by putting rats in the HBO chamber at 3 atmospheres absolute (ATA) HBO for 1 h. Glucose, lactate, pyruvate, and glutamate in striatal extracellular fluid were collected and measured by a microdialysis system at 7, 10, and 24 h after reperfusion. Glucose, pyruvate and glutamate concentrations were increased after reperfusion. HBO treatment decreased glucose, pyruvate, and glutamate almost to the control level (preocclusion level). The lactate concentration remained unchanged after ischemic/reperfusion and after HBO treatment. This study suggested that altered brain energy metabolites and excitatory amino acids occurred during cerebral ischemia and and HBO regulated these striatal metabolites, which might contribute to the protective effect of HBO in cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597594     DOI: 10.1016/s0006-8993(01)02867-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model.

Authors:  Dali Yin; John H Zhang
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

3.  Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release.

Authors:  Zhong-jin Yang; Yan Xie; Geraldo M Bosco; Chung Chen; Enrico M Camporesi
Journal:  Eur J Appl Physiol       Date:  2009-10-23       Impact factor: 3.078

Review 4.  A review on the neuroprotective effects of hyperbaric oxygen therapy.

Authors:  Fahimeh Ahmadi; Ali Reza Khalatbary
Journal:  Med Gas Res       Date:  2021 Apr-Jun

5.  Normobaric oxygen therapy in acute ischemic stroke: A pilot study in Indian patients.

Authors:  M V Padma; A Bhasin; R Bhatia; A Garg; M B Singh; M Tripathi; K Prasad
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

6.  Hyperbaric oxygen therapy ameliorates acute brain injury after porcine intracerebral hemorrhage at high altitude.

Authors:  Hai-tao Zhu; Chen Bian; Ji-chao Yuan; Xiao-jun Liao; Wei Liu; Gang Zhu; Hua Feng; Jiang-kai Lin
Journal:  Crit Care       Date:  2015-06-15       Impact factor: 9.097

7.  The Efficacy of Hyperbaric Oxygen Therapy on Middle Cerebral Artery Occlusion in Animal Studies: A Meta-Analysis.

Authors:  Yang Xu; Renjie Ji; Ruili Wei; Bo Yin; Fangping He; Benyan Luo
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

Review 8.  Normobaric oxygen treatment in acute ischemic stroke: a clinical perspective.

Authors:  Shu-Hai Shi; Zhi-Feng Qi; Yu-Min Luo; Xun-Ming Ji; Ke Jian Liu
Journal:  Med Gas Res       Date:  2016-10-14

9.  Hyperbaric oxygen increases tissue-plasminogen activator-induced thrombolysis in vitro, and reduces ischemic brain damage and edema in rats subjected to thromboembolic brain ischemia.

Authors:  Laurent Chazalviel; Benoit Haelewyn; Mickael Degoulet; Jean-Eric Blatteau; Nicolas Vallée; Jean-Jacques Risso; Stéphane Besnard; Jacques H Abraini
Journal:  Med Gas Res       Date:  2016-07-11

10.  Normobaric oxygen for cerebral ischemic injury.

Authors:  Chunhua Chen; Haimeng Cui; Zihe Li; Ruifeng Wang; Changman Zhou
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.